The approval marks a significant milestone for the American pharmaceutical company in the field of UC
The company plans to add 1700 beds by FY27 through the organic route
International Business is expected to register double-digit growth in constant currency terms
The average time of dilation lasts three to eight hours
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Operations of Line II was stopped due to a fire incident earlier
Pharma Solutions operates 10 research and development and/or production sites globally
Elegen is the only DNA manufacturer delivering the unique combination of complexity, length and NGS-verified accuracy within days
Dr Madhu will oversee Apollo's hospital business and will focus on continuing to deliver the world's best clinical outcomes
Subscribe To Our Newsletter & Stay Updated
